Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235599 · ClinicalTrials.gov registry record
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
A clinical trial, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- 10
- Enrollment target
NCT00235599 is a clinical trial that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 10 participants.
The verdict
NCT00235599 has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This project is designed to answer the question: Is there an acute IGFBP-3 response in normal children? Our specific hypothesis states that under the influence of growth hormone secretagogues, intact IGFBP-3 molecule will undergo proteolysis and liberate IGFBP-3 fragments, along with other components of the ternary complex. This proteolysis will result in measurable rise in IGFBP-3, which will indicate the subject's growth hormone status. Short children with growth hormone deficiency will not show an IGFBP-3 response.
Interventions
- PROCEDURE IGFBP-3 Stimulation Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00235599
The ClinicalTrials.gov registry entry for NCT00235599 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IGFBP-3 Stimulation Test is the first listed.
NCT00235599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00235599 about?
NCT00235599 is a clinical study titled "The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.". This project is designed to answer the question: Is there an acute IGFBP-3 response in normal children? Our specific hypothesis states that under the influence of growth hormone secretagogues, intact IGFBP-3 molecule will undergo proteolysis and liberate IGFBP-3 fragments, along with other componen...
What is the current status of trial NCT00235599?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2005-09. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00235599?
The interventions under investigation include: IGFBP-3 Stimulation Test (PROCEDURE).
Who is sponsoring clinical trial NCT00235599?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.